Atlas Trials

Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis

Clinical trial NCT04749667 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04749667
Sponsor
Haukeland University Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple SclerosisProgressive Multiple Sclerosis
Start date
2021-08-09
Primary completion
2025-03-24
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.